Mitofusin-2 regulates leukocyte adhesion and β2 integrin activation

Area of Science:

• Cell Biology
• Immunology
• Molecular Biology

Background:

• Neutrophils are key immune cells involved in inflammation and innate immunity.
• Neutrophil adhesion to endothelium is critical for their recruitment to sites of inflammation.
• Mitofusin-2 (MFN2) plays a role in neutrophil adhesion, but its precise molecular functions are not fully understood.

Purpose of the Study:

• To elucidate the molecular mechanisms by which Mitofusin-2 (MFN2) regulates neutrophil adhesion.
• To investigate the impact of MFN2 deficiency on beta2-integrin-mediated neutrophil functions.
• To explore the potential therapeutic implications of MFN2 in leukocyte adhesion disorders.

Main Methods:

• Utilized MFN2-deficient neutrophil-like HL60 cells to assess adhesion defects.
• Examined the expression of N-formylmethionyl-leucyl-phenylalanine (fMLP) receptor FPR1 and beta2 integrin activation using conformation-specific antibodies.
• Analyzed actin polymerization, cell spreading, and beta2 integrin maturation markers (CD35, CD87) following MFN2 knockdown.

Main Results:

• MFN2 deficiency impaired beta2-integrin-mediated slow-rolling and arrest, but not PSGL-1-mediated rolling.
• Adhesion defects correlated with reduced FPR1 expression and inhibited beta2 integrin activation and actin polymerization.
• MFN2 knockdown hindered beta2 integrin activation maturation and Mn2+-induced cell spreading.

Conclusions:

• MFN2 directly regulates beta2 integrin activation, a critical process for neutrophil adhesion and immune response.
• MFN2 deficiency compromises neutrophil recruitment, impacting innate immunity.
• Understanding MFN2's role may lead to new therapeutic strategies for MFN2 deficiency-related diseases.